1.
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure.
Am J Hematol
; 98(10): E281-E284, 2023 10.
Article
in English
| MEDLINE
| ID: mdl-37515433
ABSTRACT
Evaluation of IPSS-M and exploratory prognostic model for MDS at the time of HMA failure.
Subject(s)
Myelodysplastic Syndromes , Humans , Myelodysplastic Syndromes/drug therapy , Prognosis
2.
Leukemia
; 37(6): 1397-1400, 2023 06.
Article
in English
| MEDLINE
| ID: mdl-37185307